Malignancies in Korean patients with immunoglobulin G4‐related disease
- 22 May 2017
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (8) , 1028-1035
Abstract
Aim: Several studies have implicated increased risk of malignancy in patients with immunoglobulin G4‐related disease (IgG4‐RD). Hence, we first evaluated the risk and the type of malignancy in Korean IgG4‐RD patients.Method: Clinical and laboratory results of patients fulfilling the comprehensive diagnostic criteria for IgG4‐RD were retrospectively collected between January 2006 and November 2015. One hundred and eighteen patients were included, and 35 were classified as having definite, 83 as possible/probable IgG4‐RD. We compared baseline clinical and laboratory variables between patients with definite and those with possible/probable IgG4‐RD and calculated standardized incidence ratios (SIRs) for malignancies.Results: The median age was 60 years old and 91 patients (77.1%) were male. Malignancies were found in 12 of 118 patients (10.1%), and lymphoma (4, 25.0%) was the most frequent malignancy related to IgG4‐RD. Definite IgG4‐RD patients had higher serum IgG levels and frequent multiple organ involvement. The overall incidence of malignancy was increased in patients with IgG4‐RD compared to the general population (SIR 23.08 [95% CI 11.92–40.31]), and the overall risk of SIRs was highest in non‐Hodgkin lymphoma (SIR 400.00 [95% CI 109.00–1024.00]).Conclusion: Our data showed that increased risk of malignancy, especially lymphomas, was observed in Korean IgG4‐RD patients.Keywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology (2012R1A1A1002580)
This publication has 25 references indexed in Scilit:
- Primary Sjögren's syndrome and malignancy risk: a systematic review and meta-analysisAnnals of the Rheumatic Diseases, 2014
- Circulating Nucleic Acids as Biomarkers of Prostate CancerBiomarkers in Medicine, 2013
- Cancer risk in immune-mediated inflammatory diseases (IMID)Molecular Cancer, 2013
- Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in IgG4‐Related Disease: A Retrospective Multicenter StudyArthritis Care & Research, 2013
- Malignancy as a comorbidity in rheumatic diseasesRheumatology, 2012
- Risk of malignancies in IgG4-related diseaseModern Rheumatology, 2012
- Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in JapanInternational Journal of Rheumatology, 2012
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011Modern Rheumatology, 2012
- Malignancy in MyositisCurrent Rheumatology Reports, 2011
- B Cell Signaling and TumorigenesisAnnual Review of Immunology, 2005